Polyvinylpyrrolidone-Modified Taxifolin Liposomes Promote Liver Repair by Modulating Autophagy to Inhibit Activation of the TLR4/NF-κB Signaling Pathway
- PMID: 35721857
- PMCID: PMC9199375
- DOI: 10.3389/fbioe.2022.860515
Polyvinylpyrrolidone-Modified Taxifolin Liposomes Promote Liver Repair by Modulating Autophagy to Inhibit Activation of the TLR4/NF-κB Signaling Pathway
Abstract
Taxifolin (TAX) is a hepatoprotective flavanol compound, which is severely limited by poor solubility and low bioavailability. Liposomes (Lips) are used as well-recognized drug carrier systems that improve the water solubility and bioavailability of drugs, but are easily damaged by gastric juice after oral administration, resulting in the release of drugs in the gastric juice. Therefore, it is important to find materials that modify liposomes and avoid the destruction of the liposomal phospholipid bilayer structure by the gastrointestinal environment. Taxifolin liposomes (TAX-Lips) were modified by polyvinylpyrrolidone-k30 (PVP-TAX-Lips) and manufactured using a thin-film hydration technique. Particle size (109.27 ± 0.50 nm), zeta potential (-51.12 ± 3.79 mV), polydispersity coefficient (PDI) (0.189 ± 0.007), and EE (84.7 ± 0.2%) of PVP-TAX-Lips were studied. In addition, the results of in vitro release experiments indicated that the cumulative release rates of TAX-Lips and PVP-TAX-Lips were 89.73 ± 5.18% and 65.66 ± 4.86% in the simulated gastric fluid after 24 h, respectively, while the cumulative release rates were 68.20 ± 4.98% and 55.66 ± 3.92% in the simulated intestinal fluid after 24 h, respectively. Moreover, PVP-TAX-Lips were able to reverse lipopolysaccharide and D-galactosamine (LPS/D-GalN)-induced acute liver injury (ALI) by inducing autophagy to inhibit the expression levels of the TLR4/NF-κB signaling pathway and inflammatory factors, which suggested that PVP-TAX-Lips played an important role in the prevention of ALI and also provided a promising drug delivery system for the application of TAX.
Keywords: TLR4/NF-κB; acute liver injury; autophagy; liposomes; polyvinylpyrrolidone-K30; taxifolin.
Copyright © 2022 Ding, Liu, Liu, Ding, Zhao, Dong, Chen, Sun, Zhang, Zhang and Wu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
Modification of taxifolin particles with an enteric coating material promotes repair of acute liver injury in mice through modulation of inflammation and autophagy signaling pathway.Biomed Pharmacother. 2022 Aug;152:113242. doi: 10.1016/j.biopha.2022.113242. Epub 2022 Jun 9. Biomed Pharmacother. 2022. PMID: 35691160
-
Nanometerizing Taxifolin Into Selenized Liposomes to Ameliorate Its Hypoglycemic Effect by Optimizing Drug Release and Bioavailability.Int J Nanomedicine. 2025 Feb 21;20:2225-2240. doi: 10.2147/IJN.S510378. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40007903 Free PMC article.
-
Reno protective potential of taxifolin liposomes modified by chitosan in diabetic mice.Int J Biol Macromol. 2025 May;306(Pt 2):141464. doi: 10.1016/j.ijbiomac.2025.141464. Epub 2025 Feb 25. Int J Biol Macromol. 2025. PMID: 40015419
-
Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.Int J Pharm. 2017 Jan 30;517(1-2):1-7. doi: 10.1016/j.ijpharm.2016.11.056. Epub 2016 Nov 27. Int J Pharm. 2017. PMID: 27899320
-
Panax quinquefolium saponin liposomes prepared by passive drug loading for improving intestinal absorption.Drug Dev Ind Pharm. 2020 Oct;46(10):1684-1694. doi: 10.1080/03639045.2020.1820036. Drug Dev Ind Pharm. 2020. PMID: 32996345
Cited by
-
Synthesis of Taxifolin-Loaded Polydopamine for Chemo-Photothermal-Synergistic Therapy of Ovarian Cancer.Molecules. 2024 Feb 28;29(5):1042. doi: 10.3390/molecules29051042. Molecules. 2024. PMID: 38474556 Free PMC article.
References
-
- Ajji Z., Maarouf M., Khattab A., Ghazal H. (2020). Synthesis of pH-Responsive Hydrogel Based on PVP Grafted with Crotonic Acid for Controlled Drug Delivery. Radiat. Phys. Chem. 170, 108612. 10.1016/j.radphyschem.2019.108612 - DOI
LinkOut - more resources
Full Text Sources